Menopausal estrogen therapy and non-Hodgkin's lymphoma: A post-hoc analysis of women's health initiative randomized clinical trial (Q40544175)

21 September 2017

Menopausal estrogen therapy and non-Hodgkin's lymphoma: A post-hoc analysis of women's health initiative randomized clinical trial (English)

1 reference

21 September 2017

4

Jean Wactawski-Wende

1 reference

21 September 2017

2

Rowan T Chlebowski

1 reference

21 September 2017

Ikuko Kato

1

1 reference

21 September 2017

Lifang Hou

3

1 reference

21 September 2017

Roberta M Ray

5

1 reference

21 September 2017

Judith Abrams

6

1 reference

21 September 2017

Cathryn Bock

7

1 reference

21 September 2017

Pinkal Desai

8

1 reference

21 September 2017

Michael S Simon

9

1 reference

21 September 2017

language of work or name

English

0 references

publication date

27 August 2015

1 reference

International Journal of Cancer

21 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 September 2017

138

1 reference

21 September 2017

604-611

1 reference

21 September 2017

3

1 reference

21 September 2017

Cancer statistics, 2015

1 reference

AIDS-associated non-Hodgkin lymphoma

21 January 2018

1 reference

Increasing incidence of cancers associated with the human immunodeficiency virus epidemic

21 January 2018

1 reference

The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management.

21 January 2018

1 reference

Sex hormones and autoimmunity

21 January 2018

1 reference

Sex hormones and the genesis of autoimmunity

21 January 2018

1 reference

Estrogen receptor α and β in the normal immune system and in lymphoid malignancies

21 January 2018

1 reference

The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

Progesterone and autoimmune disease

21 January 2018

1 reference

The risk of lymphoma development in autoimmune diseases: a meta-analysis

21 January 2018

1 reference

Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.

21 January 2018

1 reference

Modulation of autoimmune rheumatic diseases by oestrogen and progesterone

21 January 2018

1 reference

Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use

21 January 2018

1 reference

Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study

21 January 2018

1 reference

Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study

21 January 2018

1 reference

Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study.

21 January 2018

1 reference

Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies

21 January 2018

1 reference

Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women.

21 January 2018

1 reference

Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort

21 January 2018

1 reference

Reproductive factors and non-Hodgkin lymphoma: a systematic review

21 January 2018

1 reference

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials

21 January 2018

1 reference

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

21 January 2018

1 reference

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

21 January 2018

1 reference

A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).

21 January 2018

1 reference

Synthetic progestins used in HRT have different glucocorticoid agonist properties

21 January 2018

1 reference

Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action

21 January 2018

1 reference

Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies

21 January 2018

1 reference

Reproductive factors and non-Hodgkin lymphoma risk in the California Teachers Study

21 January 2018

1 reference

Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort

21 January 2018

1 reference

Multiple myeloma precursor disease.

21 January 2018

1 reference

Hormone replacement therapy and risk of lymphomas and myelomas

21 January 2018

1 reference

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

21 January 2018

1 reference

Why is greater medication adherence associated with better outcomes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29819

1 reference

21 September 2017

1 reference